[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Gh Research Plc (GHRS)

Gh Research Plc (GHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,851,071
  • Shares Outstanding, K 68,609
  • Annual Sales, $ 0 K
  • Annual Income, $ -48,260 K
  • EBIT $ -72 M
  • EBITDA $ -71 M
  • 60-Month Beta 1.29
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.33

Options Overview Details

View History
  • Implied Volatility 70.44% (+0.95%)
  • Historical Volatility 41.17%
  • IV Percentile 2%
  • IV Rank 3.21%
  • IV High 293.99% on 02/12/26
  • IV Low 63.03% on 08/25/26
  • Expected Move (DTE 17) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 10
  • Put/Call OI Ratio 0.73
  • Today's Open Interest 477
  • Open Int (30-Day) 697
  • Expected Range 27.36 to 27.36

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.27
  • Number of Estimates 3
  • High Estimate $-0.14
  • Low Estimate $-0.38
  • Prior Year $-0.23
  • Growth Rate Est. (year over year) -17.39%

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.68 +2.55%
on 08/31/26
31.44 -12.97%
on 08/07/26
-0.71 (-2.53%)
since 07/31/26
3-Month
19.52 +40.16%
on 06/16/26
31.44 -12.97%
on 08/07/26
+2.53 (+10.19%)
since 06/01/26
52-Week
11.83 +131.28%
on 09/12/25
31.44 -12.97%
on 08/07/26
+13.86 (+102.67%)
since 08/29/25

Most Recent Stories

More News
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity

EQNX::TICKER_START (NASDAQ:HELP),(NASDAQ:DFTX),(NASDAQ:CMPS),(NASDAQ:GHRS),(NYSE:JNJ) EQNX::TICKER_END

HELP : 11.60 (-1.36%)
CMPS : 13.24 (-2.00%)
GHRS : 27.36 (+1.41%)
JNJ : 271.19 (+2.01%)
DFTX : 38.50 (-3.07%)
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients...

HELP : 11.60 (-1.36%)
CMPS : 13.24 (-2.00%)
GHRS : 27.36 (+1.41%)
JNJ : 271.19 (+2.01%)
DFTX : 38.50 (-3.07%)
GH Research Reports First Quarter 2026 Financial Results and Provides Business Update

Phase 2b results in TRD published in JAMA PsychiatryGH001-HV-106 study enrolment completed; doses selected for the global Phase 3 pivotal program of GH001...

GHRS : 27.36 (+1.41%)
GH Research's Phase Three Timeline Looks Certain, but the Market Already Moved On

Barchart Research What to Expect from GHRS Earnings GHRS Generated May 13, 2026 Current Price $21.88 EPS Estimate $$-0.27 Consensus Rating Strong Buy Average Move 4.01% GH Research's Phase Three Timeline...

GHRS : 27.36 (+1.41%)
GH Research Announces Pricing of $117.5 Million Underwritten Offering

DUBLIN, April 29, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives...

GHRS : 27.36 (+1.41%)
GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD

Phase 2b results for GH001 in TRD now published and peer-reviewed in JAMA Psychiatry New peer-reviewed article in forthcoming issue of Psychopharmacology...

GHRS : 27.36 (+1.41%)
GH Research Reports Full Year 2025 Financial Results and Provides Business Update

Completed Phase 2b trial of GH001 in TRD and presented the full dataset at the 2025 ASCP and ECNP congressesGH001 cleared by FDA for U.S. clinical...

GHRS : 27.36 (+1.41%)
Stocks Finish Higher on Strength in Chip Makers and Energy Producers

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.77%. March E-mini S&P...

MSTR : 124.88 (-6.06%)
MPC : 383.00 (+2.59%)
HL : 19.11 (-3.82%)
CDE : 20.20 (-2.79%)
ADI : 354.52 (-2.10%)
GLXY : 23.43 (-4.76%)
JNJ : 271.19 (+2.01%)
SLB : 57.15 (-4.91%)
QXO : 12.88 (-3.01%)
AMGN : 438.12 (+1.92%)
COIN : 176.82 (-6.01%)
PNR : 60.45 (-0.02%)
Chip Makers and Energy Producers Lead Stock Indexes Higher

The S&P 500 Index ($SPX ) (SPY ) today is up +0.72%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.32%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.04%. March E-mini S&P futures (ESH26...

MSTR : 124.88 (-6.06%)
MPC : 383.00 (+2.59%)
HL : 19.11 (-3.82%)
CDE : 20.20 (-2.79%)
ADI : 354.52 (-2.10%)
GLXY : 23.43 (-4.76%)
SLB : 57.15 (-4.91%)
QXO : 12.88 (-3.01%)
COIN : 176.82 (-6.01%)
PNR : 60.45 (-0.02%)
AMD : 459.61 (-2.36%)
^BTCUSD : 77,139.31 (-0.35%)
Stocks Climb on AI Spending Optimism and Strength in Energy Producers

The S&P 500 Index ($SPX ) (SPY ) today is up +0.54%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.99%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.78%. March E-mini S&P futures (ESH26...

MSTR : 124.88 (-6.06%)
AMAT : 441.85 (-3.61%)
MPC : 383.00 (+2.59%)
B : 43.10 (-3.86%)
GHRS : 27.36 (+1.41%)
CVX : 211.05 (+2.38%)
HL : 19.11 (-3.82%)
CDE : 20.20 (-2.79%)
ADI : 354.52 (-2.10%)
MBLY : 8.36 (-1.99%)
GLXY : 23.43 (-4.76%)
SLB : 57.15 (-4.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

GH Research PLC is a clinical-stage biopharmaceutical company. It dedicated to treat psychiatric and neurological disorders. The company's initial focus is on developing its novel and proprietary 5-MeO-DMT therapies for the treatment of patients with Treatment-Resistant Depression. GH Research PLC is...

See More

Key Turning Points

3rd Resistance Point 29.20
2nd Resistance Point 28.63
1st Resistance Point 27.81
Last Price 27.36
1st Support Level 26.42
2nd Support Level 25.85
3rd Support Level 25.03

See More

52-Week High 31.44
Last Price 27.36
Fibonacci 61.8% 23.95
Fibonacci 50% 21.63
Fibonacci 38.2% 19.32
52-Week Low 11.83

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.